{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:09:39Z","timestamp":1789229379148,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013420","name":"Tsumura & Co","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013420","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ahj.2023.02.013","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T11:41:48Z","timestamp":1677238908000},"page":"18-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial"],"prefix":"10.1016","volume":"260","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1011-1033","authenticated-orcid":false,"given":"Hidenori","family":"Yaku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kitai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Inuzuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yodo","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketoshi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Ezaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Isotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arita","family":"Takeshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihito","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoaki","family":"Matoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2023.02.013_bib0001","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics-2022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.02.013_bib0002","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.02.013_bib0003","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1253\/circrep.CR-19-0054","article-title":"Association of Previous hospitalization for heart failure with increased mortality in patients hospitalized for acute decompensated heart failure","volume":"1","author":"Su","year":"2019","journal-title":"Circ Rep"},{"key":"10.1016\/j.ahj.2023.02.013_bib0004","doi-asserted-by":"crossref","DOI":"10.1253\/circj.CJ-19-0342","article-title":"JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure\u2015 digest version","author":"Tsutsui","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2023.02.013_bib0005","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.02.013_bib0006","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1253\/circj.CJ-17-1386","article-title":"Demographics, management, and in-hospital outcome of hospitalized acute heart failure syndrome patients in contemporary real clinical practice in japan - observations from the prospective, multicenter kyoto congestive heart failure (KCHF) registry","volume":"82","author":"Yaku","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2023.02.013_bib0007","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/hrt.57.1.17","article-title":"Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics","volume":"57","author":"Bayliss","year":"1987","journal-title":"Br Heart J"},{"key":"10.1016\/j.ahj.2023.02.013_bib0008","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","article-title":"Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD)","volume":"82","author":"Francis","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.02.013_bib0009","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/hc1102.105264","article-title":"BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy","volume":"105","author":"Gottlieb","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.02.013_bib0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1532-5415.1999.tb01899.x","article-title":"Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs","volume":"47","author":"Leipzig","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ahj.2023.02.013_bib0011","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/archinternmed.2008.526","article-title":"Loop diuretic use and fracture in postmenopausal women: findings from the women's health initiative","volume":"169","author":"Carbone","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2023.02.013_bib0012","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10557-016-6697-7","article-title":"Cardiac dysfunction, congestion and loop diuretics: their relationship to prognosis in heart failure","volume":"30","author":"Pellicori","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ahj.2023.02.013_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2010.05.032","article-title":"Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization","volume":"160","author":"Abdel-Qadir","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2023.02.013_bib0014","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1253\/circj.CJ-16-0216","article-title":"Prognostic impact of loop diuretics in patients with chronic heart failure\u2013 effects of addition of renin-angiotensin-aldosterone system inhibitors and \u03b2-blockers","volume":"80","author":"Miura","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2023.02.013_bib0015","first-page":"131","article-title":"The verification of regulatory effects of Kampo formulations on body fluid using model mice","volume":"17","author":"Ohnishi","year":"2000","journal-title":"J Tradit Med"},{"issue":"1","key":"10.1016\/j.ahj.2023.02.013_bib0016","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13730-022-00723-0","article-title":"Impact of Goreisan upon aquaporin-2-incorporated aquaresis system in patients with congestive heart failure","volume":"12","author":"Kakeshita","year":"2023","journal-title":"CEN Case Rep."},{"key":"10.1016\/j.ahj.2023.02.013_bib0017","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.CIR.88.1.107","article-title":"Survival after the onset of congestive heart failure in Framingham Heart Study subjects","volume":"88","author":"Ho","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.02.013_bib0018","series-title":"TSUMURA Goreisan extract granules for ethical use, package insert (6th version)","year":"2014"},{"key":"10.1016\/j.ahj.2023.02.013_bib0019","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City cardiomyopathy questionnaire: a new health status measure for heart failure","volume":"35","author":"Green","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.02.013_bib0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/CIRCOUTCOMES.115.001958","article-title":"Development and validation of a short version of the Kansas City cardiomyopathy questionnaire","volume":"8","author":"Spertus","year":"2015","journal-title":"Circ Cardiovas Qual Outcomes"},{"key":"10.1016\/j.ahj.2023.02.013_bib0021","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijcard.2006.11.230","article-title":"Head-to-head comparison of B-type natriuretic peptide (BNP) and NT-proBNP in daily clinical practice","volume":"124","author":"Mair","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2023.02.013_bib0022","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006125","article-title":"Utility of the cardiovascular physical examination and impact of spironolactone in heart failure with preserved ejection fraction","volume":"12","author":"Selvaraj","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2023.02.013_bib0023","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2023.02.013_bib0024","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3923\/jms.2011.30.38","article-title":"Effects of Gorei-san: a traditional Japanese Kampo Medicine, on Aquaporin 1, 2, 3, 4 and V2R mRNA expression in rat kidney and forebrain","volume":"11","author":"Kurita","year":"2010","journal-title":"J Med Sci"},{"key":"10.1016\/j.ahj.2023.02.013_bib0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.5892","article-title":"Association of mineralocorticoid receptor antagonist use with all-cause mortality and hospital readmission in older adults with acute decompensated heart failure","volume":"2","author":"Yaku","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ahj.2023.02.013_bib0026","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cardfail.2005.03.009","article-title":"Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of vasopressin antagonism in heart failure: outcome study with tolvaptan (EVEREST)","volume":"11","author":"Gheorghiade","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.ahj.2023.02.013_bib0027","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2023.02.013_bib0028","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/jjco\/hyac034","article-title":"Overview of the ethical guidelines for medical and biological research involving human subjects in Japan","volume":"52","author":"Eba","year":"2022","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ahj.2023.02.013_bib0029","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jjcc.2021.12.011","article-title":"Kampo medicine for the holistic approach to older adults with heart failure","volume":"80","author":"Yaku","year":"2022","journal-title":"J Cardiol"},{"key":"10.1016\/j.ahj.2023.02.013_bib0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/147323000603400301","article-title":"Traditional Chinese medicine and Kampo: a review from the distant past for the future","volume":"34","author":"Yu","year":"2006","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ahj.2023.02.013_bib0031","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/535146","article-title":"Pattern classification in kampo medicine","volume":"2014","author":"Yakubo","year":"2014","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.ahj.2023.02.013_bib0032","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.fct.2007.12.005","article-title":"Amelioration of anti-cancer agent adriamycin-induced nephrotic syndrome in rats by Wulingsan (Gorei-San), a blended traditional Chinese herbal medicine","volume":"46","author":"He","year":"2008","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.ahj.2023.02.013_bib0033","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jep.2009.04.021","article-title":"The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription","volume":"124","author":"Liu","year":"2009","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ahj.2023.02.013_bib0034","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jep.2012.02.021","article-title":"Oryeongsan (Wulingsan), a traditional Chinese herbal medicine, induces natriuresis and diuresis along with an inhibition of the renin\u2013angiotensin\u2013aldosterone system in rats","volume":"141","author":"Ahn","year":"2012","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ahj.2023.02.013_bib0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2169\/internalmedicine.3030-19","article-title":"Oryeongsan (goreisan) ameliorates experimental autoimmune encephalomyelitis","volume":"59","author":"Inada","year":"2020","journal-title":"Intern Med"},{"key":"10.1016\/j.ahj.2023.02.013_bib0036","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.10.010","article-title":"Goreisan prevents brain edema after cerebral ischemic stroke by inhibiting aquaporin 4 upregulation in mice","volume":"27","author":"Nakano","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.ahj.2023.02.013_bib0037","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ejhf.462","article-title":"Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction","volume":"18","author":"Damman","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2023.02.013_bib0038","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.amjcard.2017.04.021","article-title":"Changes in loop diuretic dose and outcome after cardiac resynchronization therapy in patients with heart failure and reduced left ventricular ejection fractions","volume":"120","author":"Martens","year":"2017","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2023.02.013_bib0039","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41572-022-00376-4","volume":"8","author":"Skou","year":"2022","journal-title":"Multimorbidity, Nat Rev Dis Primers"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323000455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323000455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:59:37Z","timestamp":1762077577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870323000455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":39,"alternative-id":["S0002870323000455"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2023.02.013","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2023.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}